Texas Permanent School Fund Alkermes Plc. Transaction History

Texas Permanent School Fund

  • $597 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$23.21 - $27.24 $490,798 - $576,017
-21,146 Reduced 14.48%
124,906 $3.01 Million
Q1 2024

May 03, 2024
BUY
$26.4 - $32.56 $50,424 - $62,189
1,910 Added 1.33%
146,052 $3.95 Million
Q4 2023

Feb 08, 2024
BUY
$23.37 - $28.68 $3.37 Million - $4.13 Million
144,142 New
144,142 $4 Million

Others Institutions Holding ALKS

# of Institutions
360
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.53B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email